From: Evaluation of the Antitumor Activity of Dacomitinib in Models of Human Bladder Cancer
 | UM-UC-6 | UM-UC-9 | ||
---|---|---|---|---|
 | DMSO | Dac | DMSO | Dac |
24 h | Â | Â | Â | Â |
G1% | 39 | 81.3 | 47 | 56.3 |
S% | 43.8 | 12.7 | 36.2 | 29.9 |
G2/M% | 17.2 | 6 | 16.8 | 13.8 |
44 h | Â | Â | Â | Â |
G1% | 69.9 | 77 | 62.1 | 79 |
S% | 19.8 | 16.7 | 26.7 | 13.5 |
G2/M% | 10.3 | 6.3 | 11.2 | 7.5 |